Mesenchyme Forkhead 1 (FOXC2) Plays a Key Role in Metastasis and is Associated with Aggressive Basal-like Breast Cancers

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2007 Jun 1

PMID 17537911

Citations 302

Authors

Sendurai A Mani

Jing Yang

Mary Brooks

Gunda Schwaninger

Alicia Zhou

Naoyuki Miura

Jeffery L Kutok

Kimberly Hartwell

Andrea L Richardson

Robert A Weinberg

Affiliations

Soon will be listed here.

Abstract

The metastatic spread of epithelial cancer cells from the primary tumor to distant organs mimics the cell migrations that occur during embryogenesis. Using gene expression profiling, we have found that the FOXC2 transcription factor, which is involved in specifying mesenchymal cell fate during embryogenesis, is associated with the metastatic capabilities of cancer cells. FOXC2 expression is required for the ability of murine mammary carcinoma cells to metastasize to the lung, and overexpression of FOXC2 enhances the metastatic ability of mouse mammary carcinoma cells. We show that FOXC2 expression is induced in cells undergoing epithelial-mesenchymal transitions (EMTs) triggered by a number of signals, including TGF-beta1 and several EMT-inducing transcription factors, such as Snail, Twist, and Goosecoid. FOXC2 specifically promotes mesenchymal differentiation during an EMT and may serve as a key mediator to orchestrate the mesenchymal component of the EMT program. Expression of FOXC2 is significantly correlated with the highly aggressive basal-like subtype of human breast cancers. These observations indicate that FOXC2 plays a central role in promoting invasion and metastasis and that it may prove to be a highly specific molecular marker for human basal-like breast cancers.

Citing Articles

PFDN1 silencing disrupts critical cancer pathways in triple-negative breast cancer: investigating migration, cell cycle, and apoptosis as a new target therapy.

Alokda A, Soffar A, Yousef A, Ibrahim F, El-Sewedy T, Elmetwalli A Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 40063241 DOI: 10.1007/s00210-025-03975-6.

Classification of Breast Cancer Through the Perspective of Cell Identity Models.

Iggo R, MacGrogan G Adv Exp Med Biol. 2025; 1464():185-207.

PMID: 39821027 DOI: 10.1007/978-3-031-70875-6_11.

The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications.

Ding T, Liu C, Li Z Mol Cancer. 2025; 24(1):18.

PMID: 39815314 PMC: 11734361. DOI: 10.1186/s12943-025-02227-8.

Cancer and lymphatic marker FOXC2 drives wound healing and fibrotic tissue formation.

Granoski M, Fischer K, Hahn W, Sivaraj D, Kussie H, Quintero F Front Physiol. 2024; 15:1427113.

PMID: 39473610 PMC: 11518795. DOI: 10.3389/fphys.2024.1427113.

Copper-Based Nanomedicines for Cuproptosis-Mediated Effective Cancer Treatment.

Noh D, Lee H, Lee S, Sun I, Yoon H Biomater Res. 2024; 28:0094.

PMID: 39430913 PMC: 11486892. DOI: 10.34133/bmr.0094.

References

Sorlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H . Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001; 98(19):10869-74. PMC: 58566. DOI: 10.1073/pnas.191367098. View

Briegel K . Embryonic transcription factors in human breast cancer. IUBMB Life. 2006; 58(3):123-32. DOI: 10.1080/15216540600686870. View

J van t Veer L, Dai H, van de Vijver M, He Y, Hart A, Mao M . Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002; 415(6871):530-6. DOI: 10.1038/415530a. View

Hajra K, Fearon E . The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res. 2002; 62(6):1613-8. View

Egeblad M, Werb Z . New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002; 2(3):161-74. DOI: 10.1038/nrc745. View

Blanco M, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J . Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002; 21(20):3241-6. DOI: 10.1038/sj.onc.1205416. View

Thiery J . Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002; 2(6):442-54. DOI: 10.1038/nrc822. View

Rosivatz E, Becker I, Specht K, Fricke E, Luber B, Busch R . Differential expression of the epithelial-mesenchymal transition regulators snail, SIP1, and twist in gastric cancer. Am J Pathol. 2002; 161(5):1881-91. PMC: 1850763. DOI: 10.1016/S0002-9440(10)64464-1. View

Fidler I . The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer. 2003; 3(6):453-8. DOI: 10.1038/nrc1098. View

10.

Bridge A, Pebernard S, Ducraux A, Nicoulaz A, Iggo R . Induction of an interferon response by RNAi vectors in mammalian cells. Nat Genet. 2003; 34(3):263-4. DOI: 10.1038/ng1173. View

11.

Siegel P, Shu W, Cardiff R, Muller W, Massague J . Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc Natl Acad Sci U S A. 2003; 100(14):8430-5. PMC: 166246. DOI: 10.1073/pnas.0932636100. View

12.

Grunert S, Jechlinger M, Beug H . Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol. 2003; 4(8):657-65. DOI: 10.1038/nrm1175. View

13.

Shioiri M, Shida T, Koda K, Oda K, Seike K, Nishimura M . Slug expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients. Br J Cancer. 2006; 94(12):1816-22. PMC: 2361350. DOI: 10.1038/sj.bjc.6603193. View

14.

Hartwell K, Muir B, Reinhardt F, Carpenter A, Sgroi D, Weinberg R . The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proc Natl Acad Sci U S A. 2006; 103(50):18969-74. PMC: 1748161. DOI: 10.1073/pnas.0608636103. View

15.

Savagner P, Boyer B, Valles A, Jouanneau J, Thiery J . Modulations of the epithelial phenotype during embryogenesis and cancer progression. Cancer Treat Res. 1994; 71:229-49. DOI: 10.1007/978-1-4615-2592-9_12. View

16.

Cano A, Perez-Moreno M, Rodrigo I, Locascio A, Blanco M, del Barrio M . The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol. 2000; 2(2):76-83. DOI: 10.1038/35000025. View

17.

Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J . The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol. 2000; 2(2):84-9. DOI: 10.1038/35000034. View

18.

Elenbaas B, Spirio L, Koerner F, Fleming M, Zimonjic D, Donaher J . Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells. Genes Dev. 2001; 15(1):50-65. PMC: 312602. DOI: 10.1101/gad.828901. View

19.

Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E . The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7(6):1267-78. DOI: 10.1016/s1097-2765(01)00260-x. View

20.

Perez-Moreno M, Locascio A, Rodrigo I, Dhondt G, Portillo F, Nieto M . A new role for E12/E47 in the repression of E-cadherin expression and epithelial-mesenchymal transitions. J Biol Chem. 2001; 276(29):27424-31. DOI: 10.1074/jbc.M100827200. View